Department of Pathology and Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Hepatology. 2010 Sep;52(3):954-65. doi: 10.1002/hep.23747.
Activation of beta-catenin, the central effector of the canonical Wnt pathway and a recognized oncogene, has been implicated in hepatocellular carcinoma. We examined N-nitrosodiethylamine (DEN)-induced tumorigenesis in hepatic beta-catenin conditional knockout mice (beta-cat KO). Male beta-cat KO and age- and sex-matched littermate controls were given a single intraperitoneal DEN injection and followed for 6-12 months for hepatic tumors. Hepatic tumors were characterized for histology, proliferation, apoptosis, oxidative stress, and specific proteins by way of western blot, immunohistochemistry, and coprecipitation studies. For in vivo tumor intervention studies, specific inhibitors were administered intraperitoneally or through drinking water. Intriguingly, beta-cat KO mice showed a paradoxical increase in susceptibility to DEN-induced tumorigenesis. This accelerated tumorigenesis is due to increased injury and inflammation, unrestricted oxidative stress, fibrosis, and compensatory increase in hepatocyte proliferation secondary to platelet-derived growth factor receptor alpha (PDGFRalpha)/phosphoinositide 3-kinase (PIK3CA)/Akt activation and c-Myc overexpression. In vitro suppression of beta-catenin expression in hepatoma cells led to enhanced PDGFRalpha expression, which was abrogated in the presence of nuclear factor kappaB (NF-kappaB) inhibitor. Daily treatment of 6-month-old DEN-exposed beta-cat KO with PDGFRalpha inhibitor dramatically reduced tumor numbers and size. Inclusion of N-acetyl-L-cysteine, a known antioxidant and NF-kappaB inhibitor, in the drinking water led to complete abolition of tumorigenesis in DEN-exposed beta-cat KO.
Loss of beta-catenin impairs the liver's ability to counteract DEN-induced oxidative stress and enhances tumorigenesis through PDGFRalpha/PIK3CA/Akt signaling. Blockade of PDGFRalpha or oxidative stress dramatically affects beta-catenin-deficient tumorigenesis. Also, hepatoma cells use PDGFRalpha/PIK3CA signaling as an escape mechanism following beta-catenin suppression, and their sequential suppression profoundly impedes tumor proliferation.
β-连环蛋白(β-catenin)是经典 Wnt 通路的核心效应物,也是公认的癌基因,其在肝细胞癌中的作用已得到证实。我们检测了肝组织中条件性敲除β-连环蛋白(β-cat KO)的雄性小鼠(β-cat KO)对 N-二乙基亚硝胺(DEN)诱导的肿瘤形成的易感性。给 DEN 诱导的肝肿瘤形成的雄性β-cat KO 和年龄及性别匹配的同窝对照小鼠单次腹腔内注射 DEN,并对其进行 6-12 个月的肝脏肿瘤追踪。通过组织学、增殖、凋亡、氧化应激以及 Western blot、免疫组化和共沉淀研究检测特定蛋白质的方法,对肝肿瘤进行特征描述。针对体内肿瘤干预研究,我们采用腹腔内注射或饮水的方式给予特定抑制剂。有趣的是,β-cat KO 小鼠对 DEN 诱导的肿瘤形成的易感性呈反常增加。这种加速的肿瘤发生是由于损伤和炎症增加、不受限制的氧化应激、纤维化以及血小板衍生生长因子受体α(PDGFRα)/磷酸肌醇 3-激酶(PIK3CA)/Akt 激活和 c-Myc 过表达引起的肝实质细胞增殖的代偿性增加所致。在肝癌细胞中抑制β-catenin 表达会导致 PDGFRα 表达增加,而在核因子 kappaB(NF-κB)抑制剂存在的情况下,这种增加被阻断。用 PDGFRα 抑制剂对 DEN 暴露的 6 个月大的β-cat KO 小鼠进行每日治疗,可显著减少肿瘤数量和大小。在 DEN 暴露的β-cat KO 小鼠的饮水中添加 N-乙酰-L-半胱氨酸(一种已知的抗氧化剂和 NF-κB 抑制剂)可完全消除肿瘤发生。
β-catenin 的缺失削弱了肝脏抵抗 DEN 诱导的氧化应激的能力,并通过 PDGFRα/PIK3CA/Akt 信号增强肿瘤发生。PDGFRα 阻断或氧化应激对β-catenin 缺陷型肿瘤发生有显著影响。此外,肝癌细胞在β-catenin 抑制后会使用 PDGFRα/PIK3CA 信号作为逃逸机制,而对其进行序贯抑制会严重阻碍肿瘤增殖。